Background The majority of death-related ovarian cancer is epithelial ovarian cancer (EOC).
Regarding the Federation of Gynecology and Obstetrics (FIGO) stage IV EOC, the 5-year …

Introduction Recent studies have shown that the presence of systemic inflammation
correlates with worse outcomes in many types of cancers. The neutrophil-to-lymphocyte ratio …

BACKGROUND.: No consensus exists which patients with surgical stage 1 epithelial ovarian
should receive postoperative chemotherapy. The purpose of this study was to evaluate the …

Objective: To assess the association between pretreatment thrombocytosis, anemia, and
leukocytosis and overall survival (OS) of advanced-stage EOC. Furthermore, to develop …

Abstract Background/Aims: Prognostic value of neutrophil-to-lymphocyte ratio (NLR) and
platelet count (PC) in patients with International Federation of Gynecology and Obstetrics …

Objectives We sought to determine the impact of pretreatment plasma platelet levels,
dimerized plasmin fragment (D-dimer) and fibrinogen in recurrent epithelial ovarian cancer …

Background The mortality rate of ovarian cancer ranks first among three common
gynecological malignant tumors due to insidious onset and lack of effective early diagnosis …

Objective To determine whether preoperative platelets to lymphocyte ratio (PLR) could
predict disease stage, surgical outcome, and survival in patients with epithelial ovarian …

A total of 251 patients with epithelial ovarian cancer (EOC) treated between 2002 and 2008
was retrospectively analyzed to investigate the long-term outcomes and prognostic factors of …

Objective Prognosis in women with ovarian cancer mainly depends on International
Federation of Gynecology and Obstetrics stage and the ability to perform optimal …